Literature DB >> 15806167

Cleavage of cten by caspase-3 during apoptosis.

Su-Shun Lo1, Su Huey Lo, Su Hao Lo.   

Abstract

Normal endothelial and epithelial cells undergo apoptosis when cell adhesion and spreading are disrupted, implying a critical role of focal adhesions in cell survival. Cten is a focal adhesion molecule of the tensin family. In contrast to other tensins, cten expression is limited to very few tissues, such as the prostate, and only in epithelial cells. Here, we have explored the potential roles of cten in apoptosis. We found cten was cleaved during apoptosis induced by staurosporine in normal prostate epithelial cells. By using recombinant caspases and site-directed mutagenesis, we have identified caspase-3 as the major protease to digest cten at the DSTD(570 downward arrow)S site. The biological relevance of cten-cleaved fragments was demonstrated by cells ectopically expressing these fragments. Cten fragment (residues 571-715) containing the phosphotyrosine-binding domain significantly reduced the growth rate. Detection of cleaved poly(ADP-ribose) polymerase and annexin binding in cells expressing cten (571-715) indicated that a fraction of cells underwent apoptosis. These results demonstrate that cten is a target of caspase-3 and the resultant fragments could further promote apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15806167     DOI: 10.1038/sj.onc.1208571

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.

Authors:  Ciric To; Carol S Ringelberg; Darlene B Royce; Charlotte R Williams; Renee Risingsong; Michael B Sporn; Karen T Liby
Journal:  Carcinogenesis       Date:  2015-05-04       Impact factor: 4.944

2.  Identification of subcellular targeting sequences of Cten reveals its role in cell proliferation.

Authors:  Shiao-Ya Hong; Yi-Ping Shih; Abigail Lo; Su Hao Lo
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-10-13       Impact factor: 4.739

3.  The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis.

Authors:  Xiaolan Qian; Guorong Li; William C Vass; Alex Papageorge; Renard C Walker; Laura Asnaghi; Peter J Steinbach; Giovanna Tosato; Kent Hunter; Douglas R Lowy
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

4.  CTEN Induces Tumour Cell Invasion and Survival and Is Prognostic in Radiotherapy-Treated Head and Neck Cancer.

Authors:  Jason C Fleming; Jeongmin Woo; Karwan Moutasim; Christopher J Hanley; Steven J Frampton; Oliver Wood; Matthew Ward; Christopher H Woelk; Christian H Ottensmeier; Sassan Hafizi; Dae Kim; Gareth J Thomas
Journal:  Cancers (Basel)       Date:  2020-10-13       Impact factor: 6.639

5.  CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.

Authors:  Shiao-Ya Hong; Yi-Ping Shih; Tianhong Li; Kermit L Carraway; Su Hao Lo
Journal:  Cancer Res       Date:  2013-06-17       Impact factor: 12.701

6.  Up-regulation of C-terminal tensin-like molecule promotes the tumorigenicity of colon cancer through beta-catenin.

Authors:  Yi-Chun Liao; Nien-Tsu Chen; Yi-Ping Shih; Ying Dong; Su Hao Lo
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

Review 7.  C-terminal tensin-like (CTEN): a promising biomarker and target for cancer.

Authors:  Su Hao Lo
Journal:  Int J Biochem Cell Biol       Date:  2014-04-13       Impact factor: 5.085

8.  The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.

Authors:  Yi-Chun Liao; Lizhen Si; Ralph W deVere White; Su Hao Lo
Journal:  J Cell Biol       Date:  2006-12-26       Impact factor: 10.539

9.  Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma.

Authors:  Lo-Kong Chan; Yung-Tuen Chiu; Karen Man-Fong Sze; Irene Oi-Lin Ng
Journal:  Oncotarget       Date:  2015-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.